Sort
261,768 grants matching “gene therapy”
SEARCH FOR SELECTIVE THERAPY OF CML
$1,006,014Sloan-Kettering Institute For Cancer Res · P01 · FY2000 · CA
Pig-to-Monkey Islet Xenotransplantation
$1,005,885Bernhard Josef Hering · University Of Minnesota · U01 · FY2015 · AI
Mitigation of Radiation Induced Gastrointestinal Syndrome.
$1,005,819Andrew John Norris · Bcn Biosciences, Llc · R44 · FY2024 · AI
Non-cytotoxic augmentation of fetal hemoglobin and bone marrow reserves
$1,005,781Yogen Saunthararajah · University Of Michigan At Ann Arbor · P01 · FY2020 · HL
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$1,005,764Pablo Tamayo · University Of California, San Diego · U01 · FY2020 · CA
IGNITE: Development of novel cyclophilin B/PIKfyve inhibitors for treatment of Malignant Peripheral Nerve Sheath Tumors
$1,005,666Steven H Olson · Sanford Burnham Prebys Medical Discovery Institute · R61 · FY2020 · NS
(PQC-5) Zwitterionic NIR/Zr-89 Agents for Prostate Cancer Staging and Treatment
$1,005,598John V Frangioni · Curadel, Llc · R01 · FY2016 · CA
Patient-Derived Models of Prostate Cancer for Personalized Medicine
$1,005,497Phillip Andrew Futreal · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA
Patient-Derived Models of Prostate Cancer for Personalized Medicine
$1,005,497Nora M Navone · University Of Tx Md Anderson Can Ctr · U01 · FY2022 · CA
Systems analysis of mechanisms driving response to immunotherapy in clear cell cancers
$1,005,360Andrew J. Gentles · Stanford University · U01 · FY2025 · CA
Basic Research Support for the CCR
$1,005,224Thomas A Misteli · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,005,132Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
CTO1681 to prevent and mitigate cytokine release syndrome in CAR T-cell recipients
$1,005,131Arthur P Bertolino · Cytoagents, Inc. · R44 · FY2025 · CA
Development of a Vaccine for HIV-AIDS: Cellular Immunity
$1,005,124Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Mouse Mutant Resource
$1,005,097Leah Rae B Donahue · Jackson Laboratory · P40 · FY2011 · RR
Nuclear Factor-kappaB in Ovarian Cancer
$1,005,082Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Personalized medicine informatics for anticoagulation therapy
$1,005,004Kristen Keeling Reynolds · Pharmacogenetics Diagnostic Laboratories · R44 · FY2012 · HL
A hepatocyte-specific R-spondin mimetic bispecific fusion protein to stimulate hepatocyte regeneration in patients with acute alcoholic hepatitis
$1,005,000Jay Tibbitts · Surrozen Operating, Inc. · U01 · FY2020 · AA
Targeting DNA Repair for Cancer Therapy.
$1,005,000Peter M Glazer · Yale University · R35 · FY2025 · CA
Tracking single-cell gene expression heterogeneity and its consequences in bacterial biofilms
$1,005,000Jing Yan · Yale University · DP2 · FY2024 · GM
Unleashing T-cell anti-tumor response through repair of altered RNA splicing and antigen mimicry recognition
$1,005,000Luisa Escobar Hoyos · Yale University · DP2 · FY2025 · CA
Metabolic gatekeepers in B-cell malignancies
$1,005,000Markus Mãschen · Yale University · R35 · FY2021 · CA
Role of the Epitranscriptome in Cancer
$1,005,000Richard I. Gregory · Univ Of Massachusetts Med Sch Worcester · R35 · FY2025 · CA
Global consequences of aneuploidy on gene expression and nuclear architecture
$1,004,995Karl Ried · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Intratumor heterogeneity and tumor evolution
$1,004,995Karl Ried · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA